SAXE JON S
Insider CIK 1114914 · DRRX Director · VSTA Director · SCLN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VTGN Vistagen Therapeutics, Inc | A Award deriv | 2025-09-09 | 2025-09-11 | 17,600 | — | $0 | 17,600 | SEC↗ |
| VTGN Vistagen Therapeutics, Inc | A Award deriv | 2024-09-06 | 2024-09-10 | 14,100 | — | $0 | 14,100 | SEC↗ |
| VTGN Vistagen Therapeutics, Inc | A Award deriv | 2024-03-04 | 2024-03-06 | 12,500 | — | $0 | 12,500 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2022-03-01 | 2022-03-03 | 100,000 | — | $0 | 100,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | M Exercise deriv | 2021-03-19 | 2021-03-22 | 2,500 | — | $0 | 0 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | M Exercise | 2021-03-19 | 2021-03-22 | 2,500 | $1.50 | $3.8K | 5,751 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2020-12-30 | 2021-01-04 | 75,000 | — | $0 | 75,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | P Buy | 2020-08-21 | 2020-08-24 | 30,000 | $0.69 | $20.7K | 50,000 | SEC↗ |
| DRRX DURECT CORP | A Award deriv | 2020-06-17 | 2020-06-18 | 55,000 | — | $0 | 55,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2020-04-23 | 2020-04-27 | 75,000 | — | $0 | 75,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2019-10-21 | 2019-10-22 | 75,000 | — | $0 | 75,000 | SEC↗ |
| DRRX DURECT CORP | A Award deriv | 2019-06-19 | 2019-06-20 | 55,000 | — | $0 | 55,000 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-06-10 | 2019-06-11 | 1,200 | $0.54 | $648 | 126,487 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-06-10 | 2019-06-11 | 287 | $0.54 | $155 | 125,287 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-06-10 | 2019-06-11 | 200 | $0.54 | $108 | 126,687 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-06-10 | 2019-06-11 | 15 | $0.54 | $8 | 126,702 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-06-10 | 2019-06-11 | 300 | $0.54 | $162 | 127,002 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-06-10 | 2019-06-11 | 100 | $0.54 | $54 | 127,102 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-06-10 | 2019-06-11 | 7,898 | $0.54 | $4.3K | 135,000 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-06-10 | 2019-06-11 | 100 | $0.55 | $55 | 135,100 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-06-10 | 2019-06-11 | 1,751 | $0.55 | $963 | 136,851 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-06-10 | 2019-06-11 | 300 | $0.55 | $165 | 137,151 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-06-10 | 2019-06-11 | 1,400 | $0.55 | $770 | 138,551 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-06-10 | 2019-06-11 | 500 | $0.55 | $275 | 139,051 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-06-10 | 2019-06-11 | 300 | $0.55 | $165 | 139,351 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-06-10 | 2019-06-11 | 1,800 | $0.55 | $990 | 141,151 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-06-10 | 2019-06-11 | 400 | $0.55 | $220 | 141,551 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-06-10 | 2019-06-11 | 1,400 | $0.55 | $770 | 142,951 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-06-10 | 2019-06-11 | 3,449 | $0.56 | $1.9K | 146,400 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-06-10 | 2019-06-11 | 626 | $0.56 | $351 | 147,026 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-06-10 | 2019-06-11 | 74 | $0.56 | $41 | 147,100 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-06-10 | 2019-06-11 | 2,900 | $0.56 | $1.6K | 150,000 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-05-24 | 2019-05-28 | 4,065 | $0.63 | $2.6K | 99,065 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-05-24 | 2019-05-28 | 4,600 | $0.63 | $2.9K | 125,000 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-05-24 | 2019-05-28 | 21,335 | $0.63 | $13.4K | 120,400 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2019-05-23 | 2019-05-28 | 50,000 | — | $0 | 50,000 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-05-13 | 2019-05-14 | 864 | $0.70 | $605 | 69,954 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-05-13 | 2019-05-14 | 1,584 | $0.70 | $1.1K | 69,090 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-05-13 | 2019-05-14 | 1,391 | $0.70 | $974 | 67,506 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-05-13 | 2019-05-14 | 595 | $0.70 | $417 | 66,115 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-05-13 | 2019-05-14 | 300 | $0.70 | $210 | 65,520 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-05-13 | 2019-05-14 | 4,900 | $0.70 | $3.4K | 65,220 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-05-13 | 2019-05-14 | 1,232 | $0.70 | $862 | 60,320 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-05-13 | 2019-05-14 | 1,000 | $0.69 | $690 | 59,088 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-05-13 | 2019-05-14 | 400 | $0.69 | $276 | 58,088 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-05-13 | 2019-05-14 | 895 | $0.69 | $618 | 57,688 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-05-13 | 2019-05-14 | 779 | $0.69 | $538 | 56,793 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-05-13 | 2019-05-14 | 569 | $0.69 | $393 | 56,014 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-05-13 | 2019-05-14 | 489 | $0.69 | $337 | 55,445 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-05-13 | 2019-05-14 | 1,195 | $0.69 | $825 | 54,956 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-05-13 | 2019-05-14 | 3,100 | $0.69 | $2.1K | 53,761 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-05-13 | 2019-05-14 | 200 | $0.69 | $138 | 50,661 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-05-13 | 2019-05-14 | 699 | $0.69 | $482 | 50,461 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-05-13 | 2019-05-14 | 900 | $0.68 | $612 | 49,762 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-05-13 | 2019-05-14 | 287 | $0.68 | $195 | 48,862 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-05-13 | 2019-05-14 | 2,995 | $0.68 | $2.0K | 48,575 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-05-13 | 2019-05-14 | 380 | $0.68 | $258 | 45,580 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-05-13 | 2019-05-14 | 200 | $0.68 | $136 | 45,200 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-05-13 | 2019-05-14 | 800 | $0.70 | $560 | 85,400 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-05-13 | 2019-05-14 | 2,085 | $0.70 | $1.5K | 84,600 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-05-13 | 2019-05-14 | 400 | $0.70 | $280 | 70,354 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-05-13 | 2019-05-14 | 4,826 | $0.70 | $3.4K | 75,180 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-05-13 | 2019-05-14 | 1,600 | $0.70 | $1.1K | 76,780 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-05-13 | 2019-05-14 | 1,798 | $0.70 | $1.3K | 78,578 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-05-13 | 2019-05-14 | 37 | $0.70 | $26 | 82,515 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-05-13 | 2019-05-14 | 3,900 | $0.70 | $2.7K | 82,478 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-05-13 | 2019-05-15 | 900 | $0.70 | $630 | 86,300 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-05-13 | 2019-05-15 | 6,500 | $0.70 | $4.5K | 92,800 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-05-13 | 2019-05-15 | 2,200 | $0.71 | $1.6K | 95,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | P Buy | 2019-03-14 | 2019-03-14 | 7,920 | $1.27 | $10.1K | 20,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | P Buy | 2019-03-13 | 2019-03-14 | 12,080 | $1.26 | $15.2K | 12,080 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-03-13 | 2019-03-15 | 1,200 | $0.82 | $984 | 25,986 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-03-13 | 2019-03-15 | 100 | $0.82 | $82 | 24,286 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-03-13 | 2019-03-15 | 100 | $0.82 | $82 | 24,186 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-03-13 | 2019-03-15 | 386 | $0.82 | $317 | 24,086 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-03-13 | 2019-03-15 | 2,400 | $0.82 | $2.0K | 23,700 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-03-13 | 2019-03-15 | 100 | $0.82 | $82 | 21,300 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-03-13 | 2019-03-15 | 100 | $0.82 | $82 | 21,200 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-03-13 | 2019-03-15 | 500 | $0.82 | $410 | 21,100 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-03-13 | 2019-03-15 | 200 | $0.82 | $164 | 20,600 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-03-13 | 2019-03-15 | 400 | $0.83 | $332 | 20,400 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-03-13 | 2019-03-15 | 600 | $0.82 | $492 | 41,300 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-03-13 | 2019-03-15 | 300 | $0.82 | $246 | 40,700 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-03-13 | 2019-03-15 | 600 | $0.82 | $492 | 40,400 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-03-13 | 2019-03-15 | 200 | $0.82 | $164 | 39,800 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-03-13 | 2019-03-15 | 625 | $0.82 | $513 | 39,600 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-03-13 | 2019-03-15 | 600 | $0.82 | $492 | 38,975 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-03-13 | 2019-03-15 | 200 | $0.82 | $164 | 38,375 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-03-13 | 2019-03-15 | 100 | $0.82 | $82 | 38,175 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-03-13 | 2019-03-15 | 400 | $0.82 | $328 | 38,075 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-03-13 | 2019-03-15 | 300 | $0.82 | $246 | 37,675 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-03-13 | 2019-03-15 | 3,441 | $0.82 | $2.8K | 37,375 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-03-13 | 2019-03-15 | 4,600 | $0.82 | $3.8K | 33,934 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-03-13 | 2019-03-15 | 748 | $0.82 | $613 | 29,334 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-03-13 | 2019-03-15 | 200 | $0.82 | $164 | 28,586 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-03-13 | 2019-03-15 | 100 | $0.82 | $82 | 28,386 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-03-13 | 2019-03-15 | 1,800 | $0.82 | $1.5K | 28,286 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-03-13 | 2019-03-15 | 200 | $0.82 | $164 | 26,486 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-03-13 | 2019-03-15 | 300 | $0.82 | $246 | 26,286 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-03-13 | 2019-03-15 | 100 | $0.82 | $82 | 24,386 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-03-13 | 2019-03-15 | 400 | $0.82 | $328 | 24,786 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-03-13 | 2019-03-15 | 200 | $0.82 | $164 | 43,400 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-03-13 | 2019-03-15 | 200 | $0.82 | $164 | 44,600 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-03-13 | 2019-03-15 | 200 | $0.82 | $164 | 44,400 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-03-13 | 2019-03-15 | 600 | $0.82 | $492 | 44,200 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-03-13 | 2019-03-15 | 100 | $0.82 | $82 | 43,600 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-03-13 | 2019-03-15 | 100 | $0.82 | $82 | 43,500 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-03-13 | 2019-03-15 | 300 | $0.82 | $246 | 44,900 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-03-13 | 2019-03-15 | 800 | $0.82 | $656 | 43,200 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-03-13 | 2019-03-15 | 100 | $0.82 | $82 | 42,400 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-03-13 | 2019-03-15 | 100 | $0.82 | $82 | 42,300 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-03-13 | 2019-03-15 | 900 | $0.82 | $738 | 42,200 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2019-03-13 | 2019-03-15 | 100 | $0.82 | $82 | 45,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | M Exercise deriv | 2019-01-29 | 2019-01-30 | 375 | — | $0 | 0 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | M Exercise deriv | 2019-01-29 | 2019-01-30 | 1,000 | — | $0 | 0 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | M Exercise | 2019-01-29 | 2019-01-30 | 375 | $1.50 | $563 | 2,251 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | M Exercise | 2019-01-29 | 2019-01-30 | 1,000 | $1.50 | $1.5K | 3,251 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2018-08-29 | 2018-08-31 | 35,000 | — | $0 | 35,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | D To issuer deriv | 2018-08-29 | 2018-08-31 | 35,000 | — | $0 | 0 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2018-08-29 | 2018-08-31 | 25,000 | — | $0 | 25,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | D To issuer deriv | 2018-08-29 | 2018-08-31 | 25,000 | — | $0 | 0 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2018-08-29 | 2018-08-31 | 25,000 | — | $0 | 25,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | D To issuer deriv | 2018-08-29 | 2018-08-31 | 25,000 | — | $0 | 0 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2018-08-29 | 2018-08-31 | 2,500 | — | $0 | 2,500 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | D To issuer deriv | 2018-08-29 | 2018-08-31 | 2,500 | — | $0 | 0 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2018-08-29 | 2018-08-31 | 7,500 | — | $0 | 7,500 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | D To issuer deriv | 2018-08-29 | 2018-08-31 | 7,500 | — | $0 | 0 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2018-08-29 | 2018-08-31 | 1,000 | — | $0 | 1,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | D To issuer deriv | 2018-08-29 | 2018-08-31 | 1,000 | — | $0 | 0 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2018-08-29 | 2018-08-31 | 375 | — | $0 | 375 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | D To issuer deriv | 2018-08-29 | 2018-08-31 | 375 | — | $0 | 0 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2018-08-05 | 2018-08-06 | 75,000 | — | $0 | 75,000 | SEC↗ |
| DRRX DURECT CORP | A Award deriv | 2018-06-19 | 2018-06-20 | 55,000 | — | $0 | 55,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2018-02-02 | 2018-02-05 | 100,000 | — | $0 | 100,000 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | D To issuer deriv | 2017-10-13 | 2017-10-16 | 30,000 | $8.17 | $245.1K | 0 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | D To issuer deriv | 2017-10-13 | 2017-10-16 | 30,000 | $8.95 | $268.5K | 0 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | D To issuer deriv | 2017-10-13 | 2017-10-16 | 30,000 | $9.43 | $282.9K | 0 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | D To issuer deriv | 2017-10-13 | 2017-10-16 | 30,000 | $0.28 | $8.4K | 0 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | D To issuer deriv | 2017-10-13 | 2017-10-16 | 30,000 | $2.03 | $60.9K | 0 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | D To issuer deriv | 2017-10-13 | 2017-10-16 | 30,000 | $6.08 | $182.4K | 0 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | D To issuer deriv | 2017-10-13 | 2017-10-16 | 30,000 | $6.05 | $181.5K | 0 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | D To issuer deriv | 2017-10-13 | 2017-10-16 | 30,000 | $4.40 | $132.0K | 0 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | D To issuer deriv | 2017-10-13 | 2017-10-16 | 30,000 | $5.14 | $154.2K | 0 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | D To issuer | 2017-10-13 | 2017-10-16 | 135,000 | $11.18 | $1.51M | 0 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2017-09-19 | 2017-09-20 | 50,000 | — | $0 | 50,000 | SEC↗ |
| DRRX DURECT CORP | A Award deriv | 2017-06-19 | 2017-06-21 | 55,000 | — | $0 | 55,000 | SEC↗ |
| DRRX DURECT CORP | A Award deriv | 2017-06-19 | 2017-06-21 | 16,038 | $1.06 | $17.0K | 71,038 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | A Award deriv | 2017-06-08 | 2017-06-09 | 30,000 | — | $0 | 30,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2017-04-26 | 2017-04-28 | 35,000 | — | $0 | 35,000 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | M Exercise deriv | 2017-02-22 | 2017-02-23 | 12,700 | — | $0 | 0 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | M Exercise | 2017-02-22 | 2017-02-23 | 12,700 | $2.61 | $33.1K | 135,000 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | M Exercise deriv | 2017-02-16 | 2017-02-17 | 17,300 | — | $0 | 12,700 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | M Exercise | 2017-02-16 | 2017-02-17 | 17,300 | $2.61 | $45.2K | 122,300 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2016-11-09 | 2016-11-10 | 25,000 | — | $0 | 25,000 | SEC↗ |
| DRRX DURECT CORP | A Award deriv | 2016-06-22 | 2016-06-23 | 35,000 | — | $0 | 35,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2016-06-19 | 2016-06-21 | 25,000 | — | $0 | 25,000 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | A Award deriv | 2016-06-09 | 2016-06-13 | 30,000 | — | $0 | 30,000 | SEC↗ |
| DRRX DURECT CORP | A Award deriv | 2016-03-31 | 2016-04-04 | 14,423 | $1.04 | $15.0K | 14,423 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | M Exercise deriv | 2016-01-04 | 2016-01-06 | 30,000 | — | $0 | 0 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | M Exercise | 2016-01-04 | 2016-01-06 | 30,000 | $2.46 | $73.8K | 105,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | D To issuer deriv | 2015-11-11 | 2015-11-13 | 3,250 | — | $0 | 0 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | D To issuer deriv | 2015-11-11 | 2015-11-13 | 50,000 | — | $0 | 0 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2015-11-11 | 2015-11-13 | 20,000 | — | $0 | 20,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | D To issuer deriv | 2015-11-11 | 2015-11-13 | 20,000 | — | $0 | 0 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2015-11-11 | 2015-11-13 | 3,250 | — | $0 | 3,250 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2015-11-11 | 2015-11-13 | 50,000 | — | $0 | 50,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2015-11-11 | 2015-11-13 | 7,500 | — | $0 | 7,500 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | D To issuer deriv | 2015-11-11 | 2015-11-13 | 7,500 | — | $0 | 0 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2015-11-11 | 2015-11-13 | 2,500 | — | $0 | 2,500 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | D To issuer deriv | 2015-11-11 | 2015-11-13 | 2,500 | — | $0 | 0 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2015-09-02 | 2015-09-03 | 50,000 | — | $0 | 50,000 | SEC↗ |
| DRRX DURECT CORP | A Award deriv | 2015-06-15 | 2015-06-16 | 35,000 | — | $0 | 35,000 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | A Award deriv | 2015-06-11 | 2015-06-12 | 30,000 | — | $0 | 30,000 | SEC↗ |
| DRRX DURECT CORP | A Award deriv | 2015-03-26 | 2015-03-30 | 11,111 | — | $0 | 11,111 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | M Exercise deriv | 2015-03-04 | 2015-03-05 | 30,000 | — | $0 | 0 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | M Exercise | 2015-03-04 | 2015-03-05 | 30,000 | $3.27 | $98.1K | 75,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2015-01-11 | 2015-01-13 | 20,000 | — | $0 | 20,000 | SEC↗ |
| DRRX DURECT CORP | A Award deriv | 2014-06-16 | 2014-06-17 | 35,000 | — | $0 | 35,000 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | A Award deriv | 2014-06-12 | 2014-06-16 | 30,000 | — | $0 | 30,000 | SEC↗ |
| DRRX DURECT CORP | A Award deriv | 2014-03-28 | 2014-04-01 | 14,423 | — | $0 | 14,423 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | J Other deriv | 2014-03-19 | 2014-03-21 | 65,000 | — | $0 | 65,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2013-12-20 | 2013-12-26 | 7,500 | — | $0 | 7,500 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | D To issuer deriv | 2013-12-20 | 2013-12-26 | 50,000 | — | $0 | 0 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2013-12-20 | 2013-12-26 | 50,000 | — | $0 | 50,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | D To issuer deriv | 2013-12-20 | 2013-12-26 | 10,000 | — | $0 | 0 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2013-12-20 | 2013-12-26 | 150,000 | — | $0 | 150,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | D To issuer deriv | 2013-12-20 | 2013-12-26 | 150,000 | — | $0 | 0 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2013-12-20 | 2013-12-26 | 20,000 | — | $0 | 20,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | D To issuer deriv | 2013-12-20 | 2013-12-26 | 20,000 | — | $0 | 0 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | D To issuer deriv | 2013-12-20 | 2013-12-26 | 7,500 | — | $0 | 0 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2013-12-20 | 2013-12-26 | 50,000 | — | $0 | 50,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | D To issuer deriv | 2013-12-20 | 2013-12-26 | 50,000 | — | $0 | 0 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2013-12-20 | 2013-12-26 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | A Award deriv | 2013-06-27 | 2013-06-28 | 30,000 | — | $0 | 30,000 | SEC↗ |
| DRRX DURECT CORP | A Award deriv | 2013-06-25 | 2013-06-26 | 35,000 | — | $0 | 35,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | J Other deriv | 2013-03-03 | 2013-03-06 | 150,000 | — | $0 | 150,000 | SEC↗ |
| DRRX DURECT CORP | A Award deriv | 2013-02-05 | 2013-02-07 | 18,987 | — | $0 | 18,987 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2012-12-12 | 2012-12-14 | 5,300 | $0.91 | $4.8K | 27,810 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2012-12-12 | 2012-12-14 | 9,700 | $0.91 | $8.8K | 22,510 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2012-08-28 | 2012-08-29 | 5,000 | $0.98 | $4.9K | 12,810 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2012-08-27 | 2012-08-29 | 2,810 | $0.96 | $2.7K | 7,810 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2012-08-23 | 2012-08-27 | 5,000 | $1.00 | $5.0K | 5,000 | SEC↗ |
| DRRX DURECT CORP | A Award deriv | 2012-06-20 | 2012-06-21 | 25,000 | — | $0 | 25,000 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | A Award deriv | 2012-06-07 | 2012-06-08 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | M Exercise deriv | 2012-05-02 | 2012-05-03 | 20,000 | — | $0 | 0 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | M Exercise | 2012-05-02 | 2012-05-03 | 20,000 | $3.84 | $76.8K | 45,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2012-02-13 | 2012-02-15 | 50,000 | — | $0 | 0 | SEC↗ |